A groundbreaking medication , retatrutide, is sparking considerable excitement in the field of obesity treatment . This twin-action injectable treatment works by mimicking the effects of two gut hormones, GLP-1 and GIP, which naturally regulate appetite and encourage feelings of fullness . Early res